GSK (GSK) News Today

GSK (NYSE:GSK) will be releasing earnings before the market opens on Wednesday, July 31, Zacks reports.

O Shaughnessy Asset Management LLC raised its holdings in shares of GSK plc (NYSE:GSK - Free Report) by 10.7% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 136,740 shares of the pharmaceutical company's stock after pur

Acadian Asset Management LLC increased its position in shares of GSK plc (NYSE:GSK - Free Report) by 180.0% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 2,219,798 shares of the pharmaceutical company's stock after purchasing an add

SG Americas Securities LLC lifted its holdings in shares of GSK plc (NYSE:GSK - Free Report) by 448.7% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 17,690 shares of the pharmaceutical company's stock after purchasing a

US Bancorp DE raised its stake in shares of GSK plc (NYSE:GSK - Free Report) by 54.6% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 181,647 shares of the pharmaceutical company's stock after acquiring an additional 64,144 shares during the

QRG Capital Management Inc. grew its position in shares of GSK plc (NYSE:GSK - Free Report) by 28.1% in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 181,165 shares of the pharmaceutical company's stock after buying an additional 39,751 share

GSK plc (NYSE:GSK - Get Free Report) has received a consensus rating of "Moderate Buy" from the seven research firms that are presently covering the firm, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation, two have issued a buy recommendation and two have i

Sei Investments Co. boosted its holdings in GSK plc (NYSE:GSK - Free Report) by 24.7% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 806,934 shares of the pharmaceutical company's stock after acquiring an addition

IDEAYA Biosciences stock is up more than 16% on positive treatment data in a Phase 2 clinical trial, but after a 76% run-up, IDYA stock may need a breather

Equity Investment Corp boosted its stake in GSK plc (NYSE:GSK - Free Report) by 4.8% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,398,571 shares of the pharmaceutical company's stock after purchasing an ad

Quantbot Technologies LP cut its position in shares of GSK plc (NYSE:GSK - Free Report) by 69.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 44,556 shares of the pharmaceutical company's stock after se

Central Pacific Bank Trust Division acquired a new stake in shares of GSK plc (NYSE:GSK - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 22,549 shares of the pharmaceutical company's stock,

UBS Group downgraded shares of GSK from a "buy" rating to a "neutral" rating in a research note on Monday.

Janney Montgomery Scott LLC lifted its position in GSK plc (NYSE:GSK - Free Report) by 10.5% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 346,185 shares of the pharmaceutical company's stock after buying an additional

JTC Employer Solutions Trustee Ltd raised its holdings in GSK plc (NYSE:GSK - Free Report) by 71.3% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 21,141,012 shares of the pharmaceutical company's stock after buying an addit

GSK plc (NYSE:GSK - Get Free Report) was the target of a large increase in short interest in June. As of June 15th, there was short interest totalling 8,400,000 shares, an increase of 5.8% from the May 31st total of 7,940,000 shares. Currently, 0.4% of the company's stock are short sold. Based on an average daily volume of 3,580,000 shares, the short-interest ratio is currently 2.3 days.

Jefferies Financial Group increased their price target on GSK from $52.50 to $53.00 and gave the company a "buy" rating in a research report on Tuesday.

International Assets Investment Management LLC lowered its stake in shares of GSK plc (NYSE:GSK - Free Report) by 97.3% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,208 shares o

Wellington Management Group LLP grew its position in shares of GSK plc (NYSE:GSK - Free Report) by 14.4% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,043,624 shares of the pharmaceutical company's stock after purchasing an additional 131,

Berenberg Bank upgraded GSK to a "strong-buy" rating in a research report on Thursday.

Shares of GSK plc (NYSE:GSK - Get Free Report) have earned a consensus rating of "Hold" from the six research firms that are presently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and three have issued a

Thomasville National Bank grew its position in shares of GSK plc (NYSE:GSK - Free Report) by 5.3% during the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 453,795 shares of the pharmaceutical company's stock after purchasing an additional 23,022 shares

PNC Financial Services Group Inc. reduced its position in shares of GSK plc (NYSE:GSK - Free Report) by 27.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 297,492 shares of the pharmaceutical company's s

Nomura Holdings Inc. lifted its holdings in shares of GSK plc (NYSE:GSK - Free Report) by 40.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 118,834 shares of the pharmaceutical company's stock after pur

Fisher Asset Management LLC increased its stake in GSK plc (NYSE:GSK - Free Report) by 10.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 15,036,881 shares of the pharmaceutical company's stock after purchasing an additional 1,436,488 shares d

Northwest Bank & Trust Co acquired a new position in shares of GSK plc (NYSE:GSK - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 23,586 shares of the pharmaceutica

Optimist Retirement Group LLC bought a new stake in GSK plc (NYSE:GSK - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 31,095 shares of the pharmaceutical company's stock, valued at app

Cantor Fitzgerald L. P. increased its stake in GSK plc (NYSE:GSK - Free Report) by 7,625.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 638,657 shares of the pharmaceutical company's stock after buying an add

Hotchkis & Wiley Capital Management LLC cut its position in GSK plc (NYSE:GSK - Free Report) by 2.9% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,749,346 shares of the pharmaceutical company's stock after selling 82,570

Capital Fund Management S.A. boosted its stake in GSK plc (NYSE:GSK - Free Report) by 100.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 385,726 shares of the pharmaceutical company's stock after purchasing

Stamos Capital Partners L.P. grew its stake in GSK plc (NYSE:GSK - Free Report) by 65.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 171,170 shares of the pharmaceutical company's